Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity 2023-01-26 19:30
SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane 2023-01-26 14:31
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies 2023-01-26 12:11
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax 2023-01-26 10:34
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders 2023-01-26 09:22
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies 2023-01-26 08:11
Singleron launches single cell eQTL analysis as part of their sequencing service 2023-01-25 19:00
Amcor to report Half Year 2023 results 2023-01-25 06:10
Complete Genomics to Announce New Product Launches at AGBT General Meeting 2023-01-24 20:30
TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination 2023-01-21 05:33
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI 2023-01-20 21:50
China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering 2023-01-20 21:30
International Symposium at the Vatican on Hansen's Disease To Focus on Theme of "Leave No One Behind" 2023-01-20 21:00
Revitalize Beauty Through Science: Skincare Tech Brand AMIRO Unveils Its All-In-One LED Light Therapy Face Mask 2023-01-20 20:56
SK bioscience Appoints New Executives to Accelerate New Growth Strategies 2023-01-20 20:00
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression 2023-01-20 18:00
Global Times: Spring Festival hustle and bustle back, heralds vibrant year ahead 2023-01-20 13:26
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS 2023-01-20 13:10
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases 2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS 2023-01-20 02:00
1 118 119 120 121 122 801